PMA P150013S002
- Device
- PD-L1 IHC 22C3 PHARMDX
- Applicant
- Agilent Technologies, Inc.
- PMA number
- P150013
- Supplement
- S002
- Product code
- PLS
- Decision date
- 2016-09-23
- Classification
- Immunohistochemistry Assay, Antibody, Programmed Death-ligand 1
- Generic name
- Immunohistochemistry assay, antibody, programmed death-ligand 1
- Approval order statement
- Approval for addition of the Dako PT Link PT200 programmable water bath for pre-treatment of tissue sections when using PD-L1 IHC 22C3 pharmDx.
Current openFDA PMA Record#
- Device
- PD-L1 IHC 22C3 PHARMDX
- Applicant
- Agilent Technologies, Inc.
- PMA number
- P150013
- Supplement
- S002
- Product code
- PLS
- Generic name
- Immunohistochemistry assay, antibody, programmed death-ligand 1
- Decision date
- 2016-09-23
- Decision code
- APPR
- Date received
- 2016-06-28
- Supplement type
- Real-Time Process
- Supplement reason
- Change Design/Components/Specifications/Material
- Approval order statement
- Approval for addition of the Dako PT Link PT200 programmable water bath for pre-treatment of tissue sections when using PD-L1 IHC 22C3 pharmDx.